Differential role for PAK1 and PAK4 during the invadopodia lifecycle

References

• Haga RB, Ridley AJ. Rho GTPases: Regulation and roles in cancer cell biology. Small GTPases 2016; 7:207-21; PMID:27628050;http://dx.doi.org/10.1080/21541248.2016.1232583
   PubMedGoogle Scholar
• Buccione R, Caldieri G, Ayala I. Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev 2009; 28:137-49; PMID:19153671; http://dx.doi.org/10.1007/s10555-008-9176-1
   PubMed Web of Science ®Google Scholar
• Blouw B, Seals DF, Pass I, Diaz B, Courtneidge SA. A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo. Eur J Cell Biol 2008; 87:555-67; PMID:18417249;http://dx.doi.org/10.1016/j.ejcb.2008.02.008
   PubMed Web of Science ®Google Scholar
• Gligorijevic B, Wyckoff J, Yamaguchi H, Wang Y, Roussos ET, Condeelis J. N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci 2012; 125:724-34; PMID:22389406; http://dx.doi.org/10.1242/jcs.092726
   PubMed Web of Science ®Google Scholar
• Foxall E, Pipili A, Jones GE, Wells CM. Significance of kinase activity in the dynamic invadosome. Eur J Cell Biol 2016; 95:483-92; PMID:27465307; http://dx.doi.org/10.1016/j.ejcb.2016.07.002
   PubMed Web of Science ®Google Scholar
• King H, Nicholas NS, Wells CM. Role of p-21-Activated Kinases in Cancer Progression. Int Rev Cell Mol Biol 2014; 309:347-387; PMID:24529727
   PubMed Web of Science ®Google Scholar
• Moshfegh Y, Bravo-Cordero JJ, Miskolci V, Condeelis J, Hodgson L. A Trio-Rac1-Pak1 signalling axis drives invadopodia disassembly. Nat Cell Biol 2014; 16:574-86; PMID:24859002; http://dx.doi.org/10.1038/ncb2972
   PubMed Web of Science ®Google Scholar
• Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tetè S, Luini A, Buccione R. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci 2008; 121:369-78; PMID:18198194; http://dx.doi.org/10.1242/jcs.008037
   PubMed Web of Science ®Google Scholar
• Furmaniak-Kazmierczak E, Crawley SW, Carter RL, Maurice DH, Cote GP. Formation of extracellular matrix-digesting invadopodia by primary aortic smooth muscle cells. Circ Res 2007; 100:1328-36; PMID:17446433; http://dx.doi.org/10.1161/CIRCRESAHA.106.147744
   PubMed Web of Science ®Google Scholar
• Webb BA, Eves R, Crawley SW, Zhou S, Côté GP, Mak AS. PAK1 induces podosome formation in A7r5 vascular smooth muscle cells in a PAK-interacting exchange factor-dependent manner. Am J Physiol Cell Physiol 2005; 289:C898-907; PMID:15944209; http://dx.doi.org/10.1152/ajpcell.00095.2005
   PubMed Web of Science ®Google Scholar
• Gringel A, Walz D, Rosenberger G, Minden A, Kutsche K, Kopp P, Linder S. PAK4 and alphaPIX determine podosome size and number in macrophages through localized actin regulation. J Cell Physiol 2006; 209:568-79; PMID:16897755; http://dx.doi.org/10.1002/jcp.20777
   PubMed Web of Science ®Google Scholar
• Arias-Romero LE, Chernoff J. A tale of two Paks. Biol Cell 2008; 100:97-108; PMID:18199048; http://dx.doi.org/10.1042/BC20070109
   PubMed Web of Science ®Google Scholar
• Murray BW, Guo C, Piraino J, Westwick JK, Zhang C, Lamerdin J, Dagostino E, Knighton D, Loi CM, Zager M, et al. Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proc Natl Acad Sci U S A 2010; 107:9446-51; PMID:20439741; http://dx.doi.org/10.1073/pnas.0911863107
   PubMed Web of Science ®Google Scholar
• Viaud J, Peterson JR. An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently. Mol Cancer Ther 2009; 8:2559-65; PMID:19723886; http://dx.doi.org/10.1158/1535-7163.MCT-09-0102
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang J, Guo Q, Wang Y, Zhou Y, Peng H, Cheng M, Zhao D, Li F. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells. Cancer Lett 2012; 317:24-32; PMID:22085492; http://dx.doi.org/10.1016/j.canlet.2011.11.007
   PubMed Web of Science ®Google Scholar
• Nicholas NS, Pipili A, Lesjak MS, Ameer-Beg SM, Geh JL, Healy C, MacKenzie Ross AD, Parsons M, Nestle FO, Lacy KE, et al. PAK4 suppresses PDZ-RhoGEF activity to drive invadopodia maturation in melanoma cells. Oncotarget 2016; 7(43):70881-97; PMID:27765920.
   PubMed Web of Science ®Google Scholar
• Barac A, Basile J, Vázquez-Prado J, Gao Y, Zheng Y, Gutkind JS. Direct interaction of p21-activated kinase 4 with PDZ-RhoGEF, a G protein-linked Rho guanine exchange factor. J Biol Chem 2004; 279:6182-9; PMID:14625312; http://dx.doi.org/10.1074/jbc.M309579200
   PubMed Web of Science ®Google Scholar
• Driessens MH, Olivo C, Nagata K, Inagaki M, Collard JG. B plexins activate Rho through PDZ-RhoGEF. FEBS Lett 2002; 529:168-72; PMID:12372594; http://dx.doi.org/10.1016/S0014-5793(02)03323-9
   PubMed Web of Science ®Google Scholar
• Kasai K, Takahashi M, Osumi N, Sinnarajah S, Takeo T, Ikeda H, Kehrl JH, Itoh G, Arnheiter H. The G12 family of heterotrimeric G proteins and Rho GTPase mediate Sonic hedgehog signalling. Genes Cells 2004; 9:49-58; PMID:14723707; http://dx.doi.org/10.1111/j.1356-9597.2004.00701.x
   PubMed Web of Science ®Google Scholar
• Jaiswal M, Gremer L, Dvorsky R, Haeusler LC, Cirstea IC, Uhlenbrock K, Ahmadian MR. Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG). J Biol Chem 2011; 286:18202-12; PMID:21454492;http://dx.doi.org/10.1074/jbc.M111.226431
   PubMed Web of Science ®Google Scholar
• Bravo-Cordero JJ, Oser M, Chen X, Eddy R, Hodgson L, Condeelis J. A novel spatiotemporal RhoC activation pathway locally regulates cofilin activity at invadopodia. Curr Biol 2011; 21:635-44; PMID:21474314; http://dx.doi.org/10.1016/j.cub.2011.03.039
   PubMed Web of Science ®Google Scholar
• Nakahara H, Otani T, Sasaki T, Miura Y, Takai Y, Kogo M. Involvement of Cdc42 and Rac small G proteins in invadopodia formation of RPMI7951 cells. Genes Cells 2003; 8:1019-27; PMID:14750956; http://dx.doi.org/10.1111/j.1365-2443.2003.00695.x
   PubMed Web of Science ®Google Scholar
• Sedgwick AE, Clancy JW, Olivia Balmert M, D'Souza-Schorey C. Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion. Sci Rep 2015; 5:14748; PMID:26458510; http://dx.doi.org/10.1038/srep14748
   PubMed Web of Science ®Google Scholar
• Yu CH, Rafiq NB, Krishnasamy A, Hartman KL, Jones GE, Bershadsky AD, Sheetz MP. Integrin-matrix clusters form podosome-like adhesions in the absence of traction forces. Cell Rep 2013; 5:1456-68; PMID:24290759; http://dx.doi.org/10.1016/j.celrep.2013.10.040
   PubMed Web of Science ®Google Scholar
• Schramp M, Ying O, Kim TY, Martin GS. ERK5 promotes Src-induced podosome formation by limiting Rho activation. J Cell Biol 2008; 181:1195-210; PMID:18573916; http://dx.doi.org/10.1083/jcb.200801078
   PubMed Web of Science ®Google Scholar
• Berdeaux RL, Diaz B, Kim L, Martin GS. Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function. J Cell Biol 2004; 166:317-23; PMID:15289494; http://dx.doi.org/10.1083/jcb.200312168
   PubMed Web of Science ®Google Scholar
• Schoumacher M, Goldman RD, Louvard D, Vignjevic DM. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol 2010; 189:541-56; PMID:20421424; http://dx.doi.org/10.1083/jcb.200909113
   PubMed Web of Science ®Google Scholar
• Wells CM, Whale AD, Parsons M, Masters JR, Jones GE. PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion. J Cell Sci 2010; 123:1663-73; PMID:20406887; http://dx.doi.org/10.1242/jcs.055707
   PubMed Web of Science ®Google Scholar
• Birkenfeld J, Nalbant P, Bohl BP, Pertz O, Hahn KM, Bokoch GM. GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases. Dev Cell 2007; 12:699-712; PMID:17488622; http://dx.doi.org/10.1016/j.devcel.2007.03.014
   PubMed Web of Science ®Google Scholar
• Callow MG, Zozulya S, Gishizky ML, Jallal B, Smeal T. PAK4 mediates morphological changes through the regulation of GEF-H1. J Cell Sci 2005; 118:1861-72; PMID:15827085; http://dx.doi.org/10.1242/jcs.02313
   PubMed Web of Science ®Google Scholar
• Tian X, Tian Y, Gawlak G, Sarich N, Wu T, Birukova AA. Control of vascular permeability by atrial natriuretic peptide via a GEF-H1-dependent mechanism. J Biol Chem 2014; 289:5168-83; PMID:24352660; http://dx.doi.org/10.1074/jbc.M113.493924
   PubMed Web of Science ®Google Scholar
• Meiri D, Marshall CB, Mokady D, LaRose J, Mullin M, Gingras AC, Ikura M, Rottapel R. Mechanistic insight into GPCR-mediated activation of the microtubule-associated RhoA exchange factor GEF-H1. Nature communications 2014; 5:4857; PMID:25209408; http://dx.doi.org/10.1038/ncomms5857
   PubMed Web of Science ®Google Scholar
• Zenke FT, Krendel M, DerMardirossian C, King CC, Bohl BP, Bokoch GM. p21-activated kinase 1 phosphorylates and regulates 14-3-3 binding to GEF-H1, a microtubule-localized Rho exchange factor. J Biol Chem 2004; 279:18392-400; PMID:14970201; http://dx.doi.org/10.1074/jbc.M400084200
   PubMed Web of Science ®Google Scholar
• Coniglio SJ, Zavarella S, Symons MH. Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms. Mol Cell Biol 2008; 28:4162-72; PMID:18411304;http://dx.doi.org/10.1128/MCB.01532-07
   PubMed Web of Science ®Google Scholar
• Kosoff R, Chow HY, Radu M, Chernoff J. Pak2 kinase restrains mast cell FcepsilonRI receptor signaling through modulation of Rho protein guanine nucleotide exchange factor (GEF) activity. J Biol Chem 2013; 288:974-83; PMID:23204526;http://dx.doi.org/10.1074/jbc.M112.422295
   PubMed Web of Science ®Google Scholar
• Meiri D, Marshall CB, Greeve MA, Kim B, Balan M, Suarez F, Bakal C, Wu C, Larose J, Fine N, et al. Mechanistic insight into the microtubule and actin cytoskeleton coupling through dynein-dependent RhoGEF inhibition. Mol Cell 2012; 45:642-55; PMID:22405273; http://dx.doi.org/10.1016/j.molcel.2012.01.027
   PubMed Web of Science ®Google Scholar
• hmed T, Shea K, Masters JR, Jones GE, Wells CM. A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF. Cell Signal 2008; 20:1320-8; PMID:18424072;http://dx.doi.org/10.1016/j.cellsig.2008.02.021
   PubMed Web of Science ®Google Scholar